BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 7274327)

  • 1. WHO report. Nomenclature of the alternative activating pathway of complement.
    Eur J Immunol; 1981 Aug; 11(8):668-9. PubMed ID: 7274327
    [No Abstract]   [Full Text] [Related]  

  • 2. Nomenclature of the alternative activating pathway of complement.
    J Immunol; 1981 Sep; 127(3):1261-2. PubMed ID: 7264302
    [No Abstract]   [Full Text] [Related]  

  • 3. Nomenclature of the alternative activating pathway of complement.
    Bull World Health Organ; 1981; 59(3):489-91. PubMed ID: 6976855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. WHO-IUIS Terminology Committee. Nomenclature for factors of the HLA system.
    Cell Immunol; 1976 Feb; 21(2):382-9. PubMed ID: 1260867
    [No Abstract]   [Full Text] [Related]  

  • 5. Six years of the International Union of Immunological Societies. Presidential report, Brighton 1974.
    Cinader B
    Ann Immunol (Paris); 1975; 126(2):239-44. PubMed ID: 1103721
    [No Abstract]   [Full Text] [Related]  

  • 6. WHO-IUIS terminology committee nomenclature for factors of the HL-A system.
    Transplant Proc; 1976 Mar; 8(1):109-14. PubMed ID: 1258126
    [No Abstract]   [Full Text] [Related]  

  • 7. Complement research.
    Dierich MP; Bitter-Suermann D
    Immunol Today; 1989 Aug; 10(8):S18-20. PubMed ID: 2679639
    [No Abstract]   [Full Text] [Related]  

  • 8. Antibody-mediated alternative complement pathway activation resists inhibition by sialoglycolipids.
    Okada N; Yasuda T; Okada H
    J Immunol; 1985 May; 134(5):3316-9. PubMed ID: 2580023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of C3 via the alternative complement pathway results in fixation of C3b to the pneumococcal cell wall.
    Winkelstein JA; Abramovitz AS; Tomasz A
    J Immunol; 1980 May; 124(5):2502-6. PubMed ID: 7365262
    [No Abstract]   [Full Text] [Related]  

  • 10. Complement activating property of the protein-rich endotoxin (OEP) of Pseudomonas aeruginosa. I. Activation of both the classical and the alternative pathways of guinea pig complement.
    Inada K
    Jpn J Exp Med; 1980 Feb; 50(1):13-21. PubMed ID: 6770130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of complement in viral infections. III. Activation of the classical and alternative complement pathways by Sindbis virus.
    Hirsch RL; Winkelstein JA; Griffin DE
    J Immunol; 1980 May; 124(5):2507-10. PubMed ID: 7365263
    [No Abstract]   [Full Text] [Related]  

  • 12. IgG and complement-mediated tissue damage in the absence of C2: evidence of a functionally active C2-bypass pathway in a guinea pig model.
    Wagner E; Platt JL; Howell DN; Marsh HC; Frank MM
    J Immunol; 1999 Sep; 163(6):3549-58. PubMed ID: 10477630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. International Lymphokine Nomenclature Committee.
    Waksman BH
    J Immunol; 1980 Mar; 124(3):1510-1. PubMed ID: 7358990
    [No Abstract]   [Full Text] [Related]  

  • 14. Synthesis of factors D, B and P of the alternative pathway of complement activation, as well as of C3, by guinea-pig peritoneal macrophages in vitro.
    Bentley C; Fries W; Brade V
    Immunology; 1978 Dec; 35(6):971-80. PubMed ID: 104925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of the alternative complement pathway by Leishmania promastigotes: parasite lysis and attachment to macrophages.
    Mosser DM; Edelson PJ
    J Immunol; 1984 Mar; 132(3):1501-5. PubMed ID: 6363545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Membrane sialoglycolipids regulate the activation of alternative complement pathway by liposomes containing trinitrophenylaminocaproyldipalmitoylphosphatidylethaolamine.
    Okada N; Yasuda T; Tsumita T; Okada H
    Immunology; 1983 Jan; 48(1):129-40. PubMed ID: 6848448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regarding a nomenclature for lymphokines.
    Waksman BH
    Ann Immunol (Paris); 1980; 131C(1):119-21. PubMed ID: 7396415
    [No Abstract]   [Full Text] [Related]  

  • 18. Ability to activate the alternative complement pathway acquired by human and guinea-pig erythrocytes after contact with influenza virus.
    Lambré C; Thibon M
    Ann Immunol (Paris); 1980; 131C(2):213-21. PubMed ID: 7416718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Drug nomenclature (I). What is the international common terminology and what is its use?].
    Navarro FA
    Med Clin (Barc); 1995 Sep; 105(9):344-8. PubMed ID: 7500689
    [No Abstract]   [Full Text] [Related]  

  • 20. WHO-IUIS terminology committee. Nomenclature for factors of the HLA system.
    J Immunogenet; 1976 Dec; 3(6):435-41. PubMed ID: 1010951
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.